SCHEMBL24847167

SCHEMBL24847167

COc1ccc(CN2C(=O)CCC(n3c(=O)n(C)c4c(N5CCNCC5)c(OC)ccc43)C2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ LMNA P02545 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HCRTR2 O43614 5/20 0.36
▸ HCRTR1 O43613 4/20 0.36
▸ HTR3A P46098 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HTR6 P50406 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CMA1 P23946 1/20 0.33
▸ DDB1 Q16531 2/20 0.33
▸ CRBN Q96SW2 2/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24847994 0.89 KMT2A (0.38) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL24847993 0.88 MEN1 (0.37) MEN1KMT2ALMNAALDH1A1MAPT
Hydrochloric Acid SCHEMBL31161458 0.86 MEN1 (0.40) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27225016 0.86 MEN1 (0.42) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27166458 0.85 MEN1 (0.37) MEN1KMT2ALMNAHCRTR2HCRTR1
SCHEMBL24607672 0.84 LMNA (0.40) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL29751507 0.84 LMNA (0.40) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL31701224 0.84 MEN1 (0.46) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL23832587 0.83 HCRTR2 (0.40) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL23842066 0.83 HCRTR2 (0.40) MEN1KMT2ALMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278759-A1 MK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-01-05 — — WO disclosed
Send feedback